Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Raw Materials (2020 - 2025)

Maravai Lifesciences Holdings has reported Raw Materials over the past 6 years, most recently at $14.6 million for Q4 2025.

  • Quarterly results put Raw Materials at $14.6 million for Q4 2025, down 13.95% from a year ago — trailing twelve months through Dec 2025 was $14.6 million (down 13.95% YoY), and the annual figure for FY2025 was $14.6 million, down 13.95%.
  • Raw Materials for Q4 2025 was $14.6 million at Maravai Lifesciences Holdings, down from $16.0 million in the prior quarter.
  • Over the last five years, Raw Materials for MRVI hit a ceiling of $26.8 million in Q3 2023 and a floor of $13.5 million in Q4 2022.
  • Median Raw Materials over the past 5 years was $18.4 million (2021), compared with a mean of $18.8 million.
  • Biggest five-year swings in Raw Materials: skyrocketed 77.52% in 2021 and later plummeted 37.79% in 2024.
  • Maravai Lifesciences Holdings' Raw Materials stood at $19.7 million in 2021, then crashed by 31.63% to $13.5 million in 2022, then surged by 43.39% to $19.3 million in 2023, then fell by 12.22% to $17.0 million in 2024, then decreased by 13.95% to $14.6 million in 2025.
  • The last three reported values for Raw Materials were $14.6 million (Q4 2025), $16.0 million (Q3 2025), and $16.4 million (Q2 2025) per Business Quant data.